A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
1 matched episode
↳ whyAnalyzes the economics behind the $480,000 cancer drug discussed in the article.
↳ whyAnalyzes the economics behind the $480,000 cancer drug discussed in the article.